These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 28506871)

  • 21. Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system.
    Kaur IP; Aggarwal D; Singh H; Kakkar S
    Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1467-72. PubMed ID: 20437246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DenTimol as A Dendrimeric Timolol Analogue for Glaucoma Therapy: Synthesis and Preliminary Efficacy and Safety Assessment.
    Lancina MG; Wang J; Williamson GS; Yang H
    Mol Pharm; 2018 Jul; 15(7):2883-2889. PubMed ID: 29767982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate.
    El-Kamel AH
    Int J Pharm; 2002 Jul; 241(1):47-55. PubMed ID: 12086720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crosslinked soy protein films and their application as ophthalmic drug delivery system.
    González A; Tártara LI; Palma SD; Alvarez Igarzabal CI
    Mater Sci Eng C Mater Biol Appl; 2015 Jun; 51():73-9. PubMed ID: 25842110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro.
    Wu CJ; Huang QW; Qi HY; Guo P; Hou SX
    Pharmazie; 2006 Sep; 61(9):783-8. PubMed ID: 17020156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained release timolol maleate loaded ocusert based on biopolymer composite.
    Nair RV; S S; Suresh A; K R A; Nair SC
    Int J Biol Macromol; 2018 Apr; 110():308-317. PubMed ID: 29341922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation.
    Desai AR; Maulvi FA; Pandya MM; Ranch KM; Vyas BA; Shah SA; Shah DO
    Biomater Sci; 2018 May; 6(6):1580-1591. PubMed ID: 29708242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.
    Chiang CH; Ho JI; Chen JL
    J Ocul Pharmacol Ther; 1996; 12(4):471-80. PubMed ID: 8951683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular pharmacokinetic/pharmacodynamic modeling for timolol in rabbits using a telemetry system.
    Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
    Biol Pharm Bull; 2008 May; 31(5):970-5. PubMed ID: 18451528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of Timolol Maleate Loaded Chitosan Nanoparticles For Improved Ocular Delivery.
    Saroha A; Pandey P; Kaushik D
    Pharm Nanotechnol; 2017; 5(4):310-316. PubMed ID: 28847270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel bioadhesive hyaluronan-itaconic acid crosslinked films for ocular therapy.
    Calles JA; Tártara LI; Lopez-García A; Diebold Y; Palma SD; Vallés EM
    Int J Pharm; 2013 Oct; 455(1-2):48-56. PubMed ID: 23911915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chitosan-Gelatin Hydrogel Crosslinked With Oxidized Sucrose for the Ocular Delivery of Timolol Maleate.
    El-Feky GS; Zayed GM; Elshaier YAMM; Alsharif FM
    J Pharm Sci; 2018 Dec; 107(12):3098-3104. PubMed ID: 30165067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of O/W nanoemulsions for ophthalmic administration of timolol.
    Gallarate M; Chirio D; Bussano R; Peira E; Battaglia L; Baratta F; Trotta M
    Int J Pharm; 2013 Jan; 440(2):126-34. PubMed ID: 23078859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bimatoprost vs. timolol.
    Camras CB
    Ophthalmology; 2002 Apr; 109(4):627-8; author reply 628-9. PubMed ID: 11927409
    [No Abstract]   [Full Text] [Related]  

  • 36. Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile.
    Shokry M; Hathout RM; Mansour S
    Int J Pharm; 2018 Jul; 545(1-2):229-239. PubMed ID: 29709617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrically atomised formulations of timolol maleate for direct and on-demand ocular lens coatings.
    Mehta P; Al-Kinani AA; Haj-Ahmad R; Arshad MS; Chang MW; Alany RG; Ahmad Z
    Eur J Pharm Biopharm; 2017 Oct; 119():170-184. PubMed ID: 28625688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma.
    Ilka R; Mohseni M; Kianirad M; Naseripour M; Ashtari K; Mehravi B
    Int J Biol Macromol; 2018 Apr; 109():955-962. PubMed ID: 29154878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discoidal niosome based controlled ocular delivery of timolol maleate.
    Vyas SP; Mysore N; Jaitely V; Venkatesan N
    Pharmazie; 1998 Jul; 53(7):466-9. PubMed ID: 9742041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication.
    Hathout RM; Gad HA; Abdel-Hafez SM; Nasser N; Khalil N; Ateyya T; Amr A; Yasser N; Nasr S; Metwally AA
    Int J Pharm; 2019 Feb; 556():192-199. PubMed ID: 30553005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.